Osteoarthritis (OA) is a common degenerative joint disease, characterized by oxidative stress, excessive inflammatory responses, cartilage matrix degradation, and subchondral bone loss. However, a therapeutic strategy that simultaneously addresses these interconnected pathologies remains elusive in current nanomedicine. In this study, we prepare a DNA nanostructure with antioxidant enzyme-mimetic activities through the coordination-driven co-assembly of oligonucleotides and inorganic cerium pyrophosphate crystals. After intra-articular injection, the valence transition property of cerium ions enables the nanoparticles to scavenge reactive oxygen species, thereby ameliorating oxidative stress-induced articular cartilage damage and facilitating cartilage extracellular matrix regeneration. Meanwhile, the adenosine-rich oligonucleotide induces M2 macrophage polarization, thereby alleviating inflammatory responses. Notably, the presence of pyrophosphate anions directly inhibits osteoclast activity, facilitating subchondral bone remodeling. This work demonstrates a universal coordination-driven strategy, which can be adopted to prepare other enzyme-mimetic nanoparticles through tailoring the components and structures for the targeted treatment of diseases beyond OA.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: